LANGUAGE
KOREAN
ENGLISH
LOCATION
COMPANY
R&D
R&D Institute
GMP Center
Clinical Development Status
Publications
PRODUCTS
1st Generation
Overview
CARTISTEM
®
PNEUMOSTEM
®
2nd Generation
Overview
SMUP-IA-01
SMUP-IV-01
R&D Inquiries
BUSINESS
CDMO
CDMO Service
Core Value
Manufacturing
Global CDMO
CDMO Inquiries
CELLTREE Cord Blood Bank
MOVITA Nutritional Supplements
LUCATREE Advanced Regenerative Medicine
IR
Stock Information
Disclosure
Financial Information
IR Inquiries
PR
MEDIPOST on Media
Corporate Brochure
CONTACT US
Customer Center
R&D Inquiries
CDMO Inquiries
IR Inquiries
osteoarthritis
Korean stem cells regenerate coach Hiddink’s worn-out knee cartilage
Hiddink, designated MEDIPOST Cord Blood Honorary Ambassador
Stem Cell Drug ‘CARTISTEM’ Treatment Japanese Patent
US patent for ‘CARTISTEM’ raw material stem cell differentiation capability selection technology
Stem cell treatment ‘CARTISTEM’ patient cutting the 10 million line
Stem cell cartilage differentiation technology Singapore patent
Signed license for ‘CARTISTEM’ in India
Strengthening marketing of ‘CARTISTEM’ by participating in numerous overseas academic conferences
MEDIPOST recognized as ‘investible’ stem cell firm
‘CARTISTEM’, intensive report on Chicago’s WGN-TV
MEDIPOST paves way for ‘stem cell era’
MEDIPOST publishes stem cell research
Previous
1
2
3
4
5
6
Next
Menu